Form 4 for VRTX Vertex Pharmaceuticals
Accepted 2022-07-21 00:00:00 ET · period of report 2022-07-19 · accession 0000899243-22-026486 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2022-07-21 | 2022-07-19 | VRTX | ALTSHULER DAVID | EVP, CSO, Gbl Research | S - Sale+OE | $288.65 | -17.9K | 53.0K | -25% | -$5.16M |
| DM | 2022-07-21 | 2022-07-19 | VRTX | ALTSHULER DAVID | EVP, CSO, Gbl Research | M - OptEx | $174.33 | +17.8K | 53.9K | +49% | +$3.10M |
| DM | 2022-07-21 | 2022-07-19 | VRTX | ALTSHULER DAVID | EVP, CSO, Gbl Research | M - OptEx | $0.00 | -17.8K | 0 | -100% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2022-07-19 | S | D | 6,604 | $289.48 | 36,077 | D | — | — | (F3) Mr. Altshuler undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price. (F7) Open market sales reported on this line occurred at a weighted average price of $289.48 (range $289.11 to $290.06). |
| 2 | Common | Common Stock | 2022-07-19 | S | D | 5,737 | $288.67 | 42,681 | D | — | — | (F3) Mr. Altshuler undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price. (F6) Open market sales reported on this line occurred at a weighted average price of $288.67 (range $288.11 to $289.09). |
| 3 | Common | Common Stock | 2022-07-19 | S | D | 4,561 | $287.83 | 48,418 | D | — | — | (F5) Open market sales reported on this line occurred at a weighted average price of $287.83 (range $287.11 to $288.10). (F3) Mr. Altshuler undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price. |
| 4 | Common | Common Stock | 2022-07-19 | S | D | 963 | $286.72 | 52,979 | D | — | — | (F4) Open market sales reported on this line occurred at a weighted average price of $286.72 (range $286.07 to $287.01). (F3) Mr. Altshuler undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price. |
| 5 | Common | Common Stock | 2022-07-19 | M | A | 10,427 | $187.53 | 46,604 | D | — | — | (F1) Includes 100 shares previously purchased under the issuer's Employee Stock Purchase Plan. |
| 6 | Common | Common Stock | 2022-07-19 | M | A | 7,338 | $155.57 | 53,942 | D | — | — | |
| 7 | Derivative | Stock Option (Right to Buy) | 2022-07-19 | M | D | 10,427 | $0.00 | 3,911 | D | $187.53 · — to 2029-02-05 | 10,427 Common Stock | (F8) The option vests in 16 quarterly installments from 2/6/2019. |
| 8 | Derivative | Stock Option (Right to Buy) | 2022-07-19 | M | D | 7,338 | $0.00 | 0 | D | $155.57 · — to 2028-02-05 | 7,338 Common Stock | (F9) Fully vested. |